CSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a significant increase in short interest in February. As of February 28th, there was short interest totalling 20,000 shares, an increase of 189.9% from the February 13th total of 6,900 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 216,000 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group raised CSL to a "strong-buy" rating in a report on Thursday, January 16th.
Check Out Our Latest Stock Report on CSL
CSL Trading Up 0.7 %
CSL stock opened at $78.89 on Thursday. The business's 50 day simple moving average is $84.23 and its 200 day simple moving average is $91.52. CSL has a 12 month low of $77.37 and a 12 month high of $109.00. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58.
About CSL
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
